In the recent American Society of Clinical Oncology (ASCO) meeting, Dr. Roy Herbst from Yale Cancer Center discussed the exciting new data surrounding osimertinib (Tagrisso) in patients with EGFR-mutated non-small cell lung cancer (NSCLC) from both the LAURA and ADAURA trials. The data revealed improvements in progression-free survival (PFS) in stage III patients and the
Health
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect various organs in the body, including the kidneys. Recent analysis of medical records has indicated that individuals with SLE who are taking metformin may have lower rates of lupus nephritis, chronic kidney disease (CKD), and other complications. This finding suggests that metformin, commonly
Rheumatoid arthritis (RA) is a chronic autoimmune disease that not only affects the joints but also increases the risk of cardiovascular events and mortality in patients. Recent research conducted by Katherine P. Liao, MD, MPH, and her colleagues at Brigham and Women’s Hospital in Boston suggests that regular high-sensitivity cardiac troponin T (hs-cTnT) testing may
The recent study sheds light on the missed chances to provide proper treatment to drug overdose survivors covered by the Medicare program. This study highlights the challenges in managing chronic pain and the lack of access to essential medications and support for overdose survivors, leading to alarming statistics that indicate a higher likelihood of receiving
Recently, the FDA has approved two new immunotherapy-chemotherapy options for patients with primary advanced or recurrent endometrial cancer. This announcement marks a significant advancement in the treatment options available for patients with this type of cancer. The approval of these treatments comes as a result of successful phase III trials that demonstrated improved progression-free survival
Dr. Dean Ornish, from the University of California San Francisco, claims that an intensive lifestyle intervention can slow the progression of early Alzheimer’s disease. He boldly states, “The only side effects are good ones.” This statement suggests that the intervention not only helps with Alzheimer’s disease but also brings positive effects to other aspects of
The study conducted by Inger Jorid Berg, MD, PhD, and colleagues at Diakonhjemmet Hospital in Oslo, Norway, aimed to evaluate different approaches to follow-up care for patients with axial spondyloarthritis (axSpA). The study compared traditional in-person follow-up visits with remote monitoring and patient-initiated care. The findings of the study were presented at the European Alliance
As we delve into the realm of environmental concerns, one looming threat stands out – air pollution. Recent studies have unraveled a concerning link between maternal exposure to particulate matter (PM) and adverse pregnancy outcomes, particularly related to blood pressure complications. This revelation sheds light on the urgency of addressing this hidden risk to maternal
Dr. Erminia Massarelli, from the City of Hope in Duarte, California, recently discussed the findings of a phase II study on utilizing osimertinib (Tagrisso) in combination with consolidative stereotactic ablative radiation (SABR) for the treatment of advanced EGFR-mutant non-small cell lung cancer (NSCLC). This study was presented at the American Society of Clinical Oncology (ASCO)
The story of a woman who developed hives all over her body after breastfeeding her newborn son has shed light on a rare condition known as lactation anaphylaxis. According to Pamela Berens, MD, an ob/gyn at the McGovern Medical School at UTHealth Houston, lactation anaphylaxis is an extremely uncommon occurrence, with only a handful of